CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- 8-K Event New debt or obligation
- DEF 14A Proxy Proxy Statement
- 8-K Event Delisting notice
- 10-K Report Annual Report
- D Other Notice of Sales of Unregistered Securities
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 424B5 Offering Prospectus
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K/A Event Shareholder vote results
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- DEF 14A Proxy Proxy Statement
Page 22 of 50 · 996 filings